RNU6-255P

Across TCGA pan-cancer cohorts, RNU6-255P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-255P data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher RNU6-255P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-255P expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

TGCT, BLCA, and KIRC are the cancer types where RNU6-255P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	All	0.839	0.975	<.001	90	view →
BLCA	OS	Tertile	IV	0.195	0.484	.024	36	view →
KIRC	DFS	Tertile	II,III,IV	0.070	0.762	<.001	36	view →
SKCM	DFS	Tertile	All	0.913	0.715	.022	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-255P–TGCT (OS)

Open the TGCT breakdown →